4-Allyl-5-(2-chloro-4-methylphenyl)-4H-1,2,4-triazole-3-thiol

Catalog No. :
ACLVYE740
CAS No. :
857495-78-4
Molecular Formula :
C12H12ClN3S
Molecular Weight :
265.77

IUPAC Name:4-allyl-5-(2-chloro-4-methylphenyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione

4-Allyl-5-(2-chloro-4-methylphenyl)-4H-1,2,4-triazole-3-thiol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$258.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Allyl-5-(2-chloro-4-methylphenyl)-4H-1,2,4-triazole-3-thiol
IUPAC Name4-allyl-5-(2-chloro-4-methylphenyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione
MDL No.MFCD06662296
Molecular FormulaC12H12ClN3S
Molecular Weight265.77
SMILESSC1=NN=C(C2=CC=C(C)C=C2Cl)N1CC=C
InChI KeyLZLJBOBKQPCCCB-UHFFFAOYSA-N
Synonym5-(2-chloro-4-methyl-phenyl)-4-prop-2-enyl-2H-1,2,4-triazole-3-thione;5-(2-chloro-4-methylphenyl)-4-prop-2-enyl-2H-1,2,4-triazole-3-thione;4-Allyl-5-(2-chloro-4-methylphenyl)-4H-1,2,4-triazole-3-thiol;4-allyl-5-(2-chloro-4-methyl-phenyl)-2H-1,2,4-triazole-3-thione;4-allyl-5-(2-chloro-4-methylphenyl)-2H-1,2,4-triazole-3-thione;TIMTEC-BB SBB006403;3H-1,2,4-Triazole-3-thione, 5-(2-chloro-4-methylphenyl)-2,4-dihydro-4-(2-propen-1-yl)-
CAS No.857495-78-4

Synthetic Route by SureRoute

1. ACLVYE740 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLVYE740 route product structure diagram
    ACLVYE740857495-78-4
Inquiry

2. ACLVYE740 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACRCIZ891 route compound structure diagram
    ACRCIZ891145349-62-8 In Stock
  4. Then
  5. ACLVYE740 route product structure diagram
    ACLVYE740857495-78-4
Inquiry

Comments (0)